Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals Inc.
WKN: 881535 / Symbol: REGN / Name: Regeneron / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
684,60 €
-0,76 %
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $255.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $798.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at BMO Capital Markets from $725.00 to $850.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "buy" rating. They now have a $860.00 price target on the stock, up previously from $627.00.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at Truist Financial Corporation from $798.00 to $820.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for REGN provided by MarketBeat
Neueste Beiträge
StockNews_com in Acadia Pharmaceuticals diskutieren